Company · CIK 1600620
Aurinia Pharmaceuticals Inc.
| CIK | 1600620 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | Alberta, Canada |
| Listed | AUPH (Nasdaq) |
| First annual or quarterly report | 2015-03-30 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-261242 | 2021-11-19 | 2021-11-19 | 1 |
Filings
4| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2021-11-19 | S-3ASRShelf registered | 333-261242 | 0001193125-21-335311 |
| 2020-06-19 | EFFECTDeclared effective | 333-238785 | 9999999995-20-001488 |
| 2018-03-29 | EFFECTDeclared effective | 333-222413 | 9999999995-18-000708 |
| 2015-11-05 | EFFECTDeclared effective | 333-206994 | 9999999995-15-002978 |